Ingemar Turesson

Ingemar Turesson

UNVERIFIED PROFILE

Are you Ingemar Turesson?   Register this Author

Register author
Ingemar Turesson

Ingemar Turesson

Publications by authors named "Ingemar Turesson"

Are you Ingemar Turesson?   Register this Author

77Publications

598Reads

Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study.

Haematologica 2018 Sep 22;103(9):e412-e415. Epub 2018 Mar 22.

Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland

View Article
September 2018

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes.

Biomark Res 2018 14;6:21. Epub 2018 Jun 14.

1Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article
June 2018

Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival.

Eur J Haematol 2018 Apr 20. Epub 2018 Apr 20.

Myeloma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article
April 2018

History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.

Ann Hematol 2017 Feb 2;96(2):261-269. Epub 2016 Nov 2.

Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, 171 76, Stockholm, Sweden.

View Article
February 2017

Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma.

Leuk Lymphoma 2015 11;56(9):2650-9. Epub 2015 Feb 11.

a Department of Hematology , Rigshospitalet, University of Copenhagen , Copenhagen , Denmark.

View Article
August 2016

Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.

Haematologica 2016 Apr 17;101(4):e145-8. Epub 2015 Dec 17.

Faculty of Medicine, University of Iceland, Reykjavik, Iceland Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

View Article
April 2016

Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.

BMJ Open 2016 Jan 21;6(1):e009584. Epub 2016 Jan 21.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

View Article
January 2016

Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease.

Haematologica 2015 Dec 20;100(12):e511-4. Epub 2015 Aug 20.

K.G. Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway

View Article
December 2015

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.

Cell Commun Signal 2015 Jun 6;13:27. Epub 2015 Jun 6.

K.G. Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Post box 8905, MTFS, N-7491, Trondheim, Norway.

View Article
June 2015

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Nat Commun 2015 May 26;6:7213. Epub 2015 May 26.

1] Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, BMC B13, SE-221 84 Lund, Sweden [2] Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Akutgatan 8, SE-221 85 Lund, Sweden [3] Broad Institute, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.

View Article
May 2015

The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.

JAMA Oncol 2015 May;1(2):168-74

Faculty of Medicine, University of Iceland, Reykjavik, Iceland3Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

View Article
May 2015

Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.

Blood 2015 Mar;125(13):2174-5

Faculty of Medicine, University of Iceland, Reykjavik, Iceland Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

View Article
March 2015

Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.

Haematologica 2015 Jan 24;100(1):107-13. Epub 2014 Oct 24.

Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

View Article
January 2015

Robust isolation of malignant plasma cells in multiple myeloma.

Blood 2014 Feb 2;123(9):1336-40. Epub 2014 Jan 2.

Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Sweden;

View Article
February 2014

Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.

Haematologica 2012 Jun 16;97(6):854-8. Epub 2011 Dec 16.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
June 2012

Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.

Acta Haematol 2012 3;127(3):173-7. Epub 2012 Feb 3.

Division of Hematology, Department of Medicine, Karolinska University Hospital, Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
May 2012

Second malignancies after multiple myeloma: from 1960s to 2010s.

Blood 2012 Mar 6;119(12):2731-7. Epub 2012 Feb 6.

Multiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article
March 2012

Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.

Blood 2011 Dec 13;118(24):6284-91. Epub 2011 Oct 13.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
December 2011

Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).

Blood 2011 Oct 27;118(15):4086-92. Epub 2011 Jul 27.

Multiple Myeloma Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article
October 2011

The association of cancer and venous thrombosis: yes, Trousseau is right...again!

Leuk Lymphoma 2011 May 4;52(5):734-5. Epub 2011 Apr 4.

Division of Hematology, Department of Medicine, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
May 2011

Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study.

Blood 2010 Oct 7;116(15):2651-5. Epub 2010 Jul 7.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
October 2010

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.

Blood 2010 Jun 18;115(24):4991-8. Epub 2010 Mar 18.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
June 2010

Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.

J Natl Cancer Inst 2010 Apr 24;102(8):557-67. Epub 2010 Feb 24.

Department of Medicine, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden.

View Article
April 2010

[Diagnosis and follow up of patients with small M components. With the view to avoid transformation to malignant disease].

Lakartidningen 2010 Jan 27-Feb 2;107(4):176-9

VO hematologi Malmö-Lund, Universitetssjukhuset MAS, Malmö.

View Article
March 2010

Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study.

J Clin Oncol 2010 Feb 28;28(5):830-4. Epub 2009 Dec 28.

Department of Medicine, Section of Hematology, Malmö University Hospital, S-2052 Malmö, Sweden.

View Article
February 2010

Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.

Haematologica 2009 Dec 16;94(12):1714-20. Epub 2009 Jul 16.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
December 2009

Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

Int J Cancer 2009 Nov;125(9):2147-50

Department of Medicine, Division of Hematology, Karolinska University Hospital, Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
November 2009

Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Haematologica 2009 Nov 7;94(11):1581-9. Epub 2009 Jul 7.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
November 2009

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.

Blood 2009 Jul 30;114(4):791-5. Epub 2009 Jan 30.

Division of Cancer Epidemiology and Genetics, and Center for Cancer Research, Medical Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.

View Article
July 2009

Highly increased familial risks for specific lymphoma subtypes.

Br J Haematol 2009 Jun 4;146(1):91-4. Epub 2009 May 4.

Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892-7236, USA.

View Article
June 2009

Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.

Haematologica 2009 May 13;94(5):647-53. Epub 2009 Mar 13.

Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., Bethesda, MD 20892, USA.

View Article
May 2009

Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.

Clin Lymphoma Myeloma 2009 Mar;9(1):19-22

Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article
March 2009

Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia.

Clin Lymphoma Myeloma 2009 Mar;9(1):23-6

Department of Medicine, Division of Hematology, Karolinska University Hospital, Solna and Karolinska Institutet, Stockholm, Sweden.

View Article
March 2009

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma.

Blood 2008 Nov 17;112(9):3582-6. Epub 2008 Jun 17.

Department of Medicine, Division of Hematology, Karolinska University Hospital and Institutet, Stockholm, Sweden.

View Article
November 2008

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.

Blood 2008 Oct 13;112(8):3052-6. Epub 2008 Aug 13.

Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden. .

View Article
October 2008

Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.

Int J Cancer 2007 Nov;121(10):2260-6

Section of Hematology, Department of Medicine, Malmö University Hospital, University of Lund, Malmö, Sweden.

View Article
November 2007

Risk of malignant disease among 1525 adult male US Veterans with Gaucher disease.

Arch Intern Med 2007 Jun;167(11):1189-94

Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.

View Article
June 2007

Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.

Blood 2006 Feb 6;107(3):904-6. Epub 2005 Oct 6.

Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH/DHHS, Bethesda, MD 20892-7236, USA.

View Article
February 2006

A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma.

Haematologica 2004 May;89(5):552-6

Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, MTFS, N-7489 Trondheim, Norway.

View Article
May 2004

Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy.

Br J Haematol 2002 Dec;119(3):672-6

Department of IMPI, Division of Pathology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.

View Article
December 2002